Motion debated, That the Parliament welcomes the licensing of the first vaccine against strains of the human papilloma virus (HPV) responsible for around 70% of cases of cervical cancer; expresses its concern that, despite a 40-year history of cervical screening in the United Kingdom, almost 3,000 women are diagnosed and 1,000 women still die of cervical cancer each year in the UK; recognises that the vaccine will not prevent all cases of cervical cancer and that it is not known whether it will prevent cancer in women already infected with HPV; therefore believes that the cervical cancer screening programme should be continued and that further action should be taken to increase the take-up of screening in more deprived areas, among ethnic minority groups and among women with learning difficulties; further believes that this will improve early detection and allow earlier treatment of this disease; recognises the role of charities such as Jo's Trust, Cancerbackup and Cancer Research UK, amongst others, in supporting patients with cervical cancer and their families and in counselling the thousands more women who worry about their health following...